| # | Drug | Count |
|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 147 |
| 1 | TREPROSTINIL | 76 |
| 2 | SILDENAFIL CITRATE | 65 |
| 3 | EPOPROSTENOL | 62 |
| 4 | MACITENTAN | 60 |
| 5 | TADALAFIL | 46 |
| 6 | AMBRISENTAN | 42 |
| 7 | ACETAMINOPHEN | 41 |
| 8 | SILDENAFIL | 38 |
| 9 | FUROSEMIDE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 147 | 0.0167 |
| 1 | EPOPROSTENOL | 62 | 0.0047 |
| 2 | TRABECTEDIN | 8 | 0.0034 |
| 3 | ETEPLIRSEN | 6 | 0.0025 |
| 4 | PEGFILGRASTIM | 20 | 0.0017 |
| 5 | ENTACAPONE | 7 | 0.0016 |
| 6 | ELOSULFASE ALFA | 9 | 0.0016 |
| 7 | LARONIDASE | 6 | 0.0015 |
| 8 | APREPITANT | 10 | 0.0013 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 133 |
| 1 | Endothelin Receptor Antagonist [EPC] | 99 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 71 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 64 |
| 4 | Corticosteroid [EPC] | 61 |
| 5 | Benzodiazepine [EPC] | 40 |
| 6 | Loop Diuretic [EPC] | 37 |
| 7 | Alkylating Drug [EPC] | 34 |
| 8 | Osmotic Laxative [EPC] | 32 |
| 9 | Proton Pump Inhibitor [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catechol-O-Methyltransferase Inhibitor [EPC] | 12 | 0.0024 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 20 | 0.0015 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 10 | 0.0011 |
| 3 | Provitamin D2 Compound [EPC] | 29 | 0.0010 |
| 4 | Prostacycline Vasodilator [EPC] | 133 | 0.0010 |
| 5 | Surfactant [EPC] | 1 | 0.0009 |
| 6 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 22 | 0.0008 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 26 | 0.0008 |
| 8 | Lipopeptide Antibacterial [EPC] | 7 | 0.0007 |
| 9 | Nonergot Dopamine Agonist [EPC] | 11 | 0.0007 |